Julien Gillet-Daubin

CAPITAL CELL

Investment Director

https://www.linkedin.com/in/julien-gillet-daubin/

Description

Julien Gillet-Daubin is an accomplished professional, currently serving as Investment Director at Capital Cell, the world’s leading alternative investment platform for early-stage biotech and life science companies. His career is marked by a series of leadership roles in the health tech industry. From 2019 to 2023, he served as Interim CEO of BIO-ELPIDA, a CDMO specializing in cell and gene therapy, where he successfully led a three-year remediation plan and orchestrated the total sale of the business to a major industrial player. Prior to that, he co-founded NEOLYS Diagnostics, an INSERM spin-off, and was its CEO for eight years, during which he developed a robust business model, secured seven patents, and raised critical funding through various investment rounds.

This speaker will talk about

Find here the list of all the sessions presented by this speaker in order not to miss any of it.

Panel | Structuring Healthtech Investments for Sustainable Growth